Literature DB >> 30744489

Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review.

Jerome R Lechien1,2,3,4, Lee M Akst5, Abdul Latif Hamdan1,6, Antonio Schindler1,7, Petros D Karkos1,8, Maria Rosaria Barillari1,9, Christian Calvo-Henriquez1,10, Lise Crevier-Buchman1,11, Camille Finck1,2,12, Young-Gyu Eun1,13, Sven Saussez1,2,4, Michael F Vaezi14.   

Abstract

OBJECTIVE: To review the current literature about the epidemiology, clinical presentation, diagnosis, and treatment of laryngopharyngeal reflux (LPR). DATA SOURCES: PubMed, Cochrane Library, and Scopus.
METHODS: A comprehensive review of the literature on LPR epidemiology, clinical presentation, diagnosis, and treatment was conducted. Using the PRISMA statement, 3 authors selected relevant publications to provide a critical analysis of the literature.
CONCLUSIONS: The important heterogeneity across studies in LPR diagnosis continues to make it difficult to summarize a single body of thought. Controversies persist concerning epidemiology, clinical presentation, diagnosis, and treatment. No recent epidemiologic study exists regarding prevalence and incidence with the use of objective diagnostic tools. There is no survey that evaluates the prevalence of symptoms and signs on a large number of patients with confirmed LPR. Regarding diagnosis, an increasing number of authors used multichannel intraluminal impedance-pH monitoring, although there is no consensus regarding standardization of the diagnostic criteria. The efficiency of proton pump inhibitor (PPI) therapy remains poorly demonstrated and misevaluated by incomplete clinical tools that do not take into consideration many symptoms and extralaryngeal findings. Despite the recent advances in knowledge about nonacid LPR, treatment protocols based on PPIs do not seem to have evolved. IMPLICATIONS FOR PRACTICE: The development of multichannel intraluminal impedance-pH monitoring and pepsin and bile salt detection should be considered for the establishment of a multiparameter diagnostic approach. LPR treatment should evolve to a more personalized regimen, including diet, PPIs, alginate, and magaldrate according to individual patient characteristics. Multicenter international studies with a standardized protocol could improve scientific knowledge about LPR.

Entities:  

Keywords:  gastroesophageal; laryngitis; laryngopharyngeal reflux

Mesh:

Year:  2019        PMID: 30744489     DOI: 10.1177/0194599819827488

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  41 in total

1.  Reflux clinic: proof-of-concept of a Multidisciplinary European Clinic.

Authors:  Marc Remacle; Stephane Hans; Jerome R Lechien; Francois Bobin; Vinciane Muls; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-23       Impact factor: 2.503

2.  Laryngopharyngeal reflux after thyroidectomy.

Authors:  Jerome R Lechien; Marie Verhasselt; Didier Dequanter; Alexandra Rodriguez; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-29       Impact factor: 2.503

3.  Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux.

Authors:  Jerome R Lechien; Francois Bobin; Francois Mouawad; Karol Zelenik; Christian Calvo-Henriquez; Carlos M Chiesa-Estomba; Necati Enver; Andrea Nacci; Maria Rosaria Barillari; Antonio Schindler; Lise Crevier-Buchman; Stéphane Hans; Virginie Simeone; Elzbieta Wlodarczyk; Bernard Harmegnies; Marc Remacle; Alexandra Rodriguez; Didier Dequanter; Pierre Eisendrath; Giovanni Dapri; Camille Finck; Petros Karkos; Hillevi Pendleton; Tareck Ayad; Vinciane Muls; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-12       Impact factor: 2.503

4.  A new diagnostic paradigm for laryngopharyngeal reflux disease: correlation of impedance-pH monitoring and digital reflux scintigraphy results.

Authors:  Jin-Soo Park; Oleksandr Khoma; Leticia Burton; Hans Van der Wall; Gregory Leighton Falk
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-13       Impact factor: 2.503

5.  Impact of subspecialty training on management of laryngopharyngeal reflux: results of a worldwide survey.

Authors:  Lee M Akst; Jonathan M Bock; Jerome R Lechien; Thomas L Carroll; Jacqueline E Allen; Tareck Ayad; Necati Enver; Young-Gyu Eun; Paulo S Perazzo; Fabio Pupo Ceccon; Geraldo D Sant'Anna; Rui Imamura; Sampath Kumar Raghunandhan; Carlos M Chiesa-Estomba; Christian Calvo-Henriquez; Sven Saussez; Petros D Karkos; Marc Remacle
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-27       Impact factor: 2.503

6.  Modified Reflux Scintigraphy Detects Pulmonary Microaspiration in Severe Gastro-Esophageal and Laryngopharyngeal Reflux Disease.

Authors:  Jin-Soo Park; Leticia Burton; Hans Van der Wall; Gregory Leighton Falk
Journal:  Lung       Date:  2021-03-09       Impact factor: 2.584

7.  Validity and reliability of the French version of Eating Assessment Tool (EAT-10).

Authors:  Jérôme R Lechien; Gaëtan Cavelier; Marie-Paule Thill; Kathy Huet; Bernard Harmegnies; Laura Bousard; Serge Blecic; Jan Vanderwegen; Alexandra Rodriguez; Didier Dequanter
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-20       Impact factor: 2.503

8.  Usefulness, acceptation and feasibility of electronic medical history tool in reflux disease.

Authors:  Jerome R Lechien; Anaïs Rameau; Lisa G De Marrez; Gautier Le Bosse; Karina Negro; Andra Sebestyen; Robin Baudouin; Sven Saussez; Stéphane Hans
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-28       Impact factor: 2.503

9.  Atypical Clinical Presentation of Laryngopharyngeal Reflux: A 5-Year Case Series.

Authors:  Jerome R Lechien; Stéphane Hans; Francois Bobin; Christian Calvo-Henriquez; Sven Saussez; Petros D Karkos
Journal:  J Clin Med       Date:  2021-05-31       Impact factor: 4.241

Review 10.  Pepsin and Laryngeal and Hypopharyngeal Carcinomas.

Authors:  Cheng-Yi Yin; Sha-Sha Zhang; Jiang-Tao Zhong; Shui-Hong Zhou
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-07-24       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.